Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy

Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors

(2018) Youichi Ohno et al.   HYPERTENSION RESEARCH

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma

(2017) Dipti Rao et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years

(2017) Oksana Hamidi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis

(2016) Laurence Amar et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma: Table 1

(2016) P F Plouin et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

(2014) Noriko Kimura et al.   ENDOCRINE-RELATED CANCER

MANAGEMENT OF ENDOCRINE DISEASE: Clinical management of paragangliomas

(2014) Eleonora P Corssmit et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

(2014) Jacques W. M. Lenders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Predictors of recurrence in pheochromocytoma

(2014) Danielle Press et al.   SURGERY

Malignant pheochromocytoma and paraganglioma: A population level analysis of long-term survival over two decades

(2012) Paolo Goffredo et al.   JOURNAL OF SURGICAL ONCOLOGY

Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma

(2011) G. Eisenhofer et al.   CLINICAL CHEMISTRY

Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification

(2011) Graeme Eisenhofer et al.   ENDOCRINE PATHOLOGY

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

(2011) Graeme Eisenhofer et al.   EUROPEAN JOURNAL OF CANCER

Predictive Factors for Malignant Pheochromocytoma: Analysis of 136 Patients

(2011) Feng Feng et al.   JOURNAL OF UROLOGY

Genetics of pheochromocytomas and paragangliomas

(2010) Giuseppe Opocher et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

(2010) Montserrat Ayala-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Size of the Tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy?

(2010) Amit Agarwal et al.   WORLD JOURNAL OF SURGERY

Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score

(2009) David Wu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes

(2009) B. Pasini et al.   JOURNAL OF INTERNAL MEDICINE

Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial

(2009) G. A. Wiseman et al.   JOURNAL OF NUCLEAR MEDICINE

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis

(2008) Vivian E. Strong et al.   SURGERY